Gregory W. Adams

Array ( [id] => 4886309 [patent_doc_number] => 20080260641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Human Monoclonal Antibodies Against Cd20' [patent_app_type] => utility [patent_app_number] => 11/578818 [patent_app_country] => US [patent_app_date] => 2005-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 29242 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260641.pdf [firstpage_image] =>[orig_patent_app_number] => 11578818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 133235 [patent_doc_number] => 07696307 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Function and regulation of ADAMTS-1' [patent_app_type] => utility [patent_app_number] => 11/104075 [patent_app_country] => US [patent_app_date] => 2005-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21427 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696307.pdf [firstpage_image] =>[orig_patent_app_number] => 11104075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33112 [patent_doc_number] => 07785903 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Variable domain library and uses' [patent_app_type] => utility [patent_app_number] => 11/102502 [patent_app_country] => US [patent_app_date] => 2005-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 36582 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785903.pdf [firstpage_image] =>[orig_patent_app_number] => 11102502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4456916 [patent_doc_number] => 07893216 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Anti-human trail receptor DR5 monoclonal antibody (AD5-10), method thereof and use of the same' [patent_app_type] => utility [patent_app_number] => 11/596271 [patent_app_country] => US [patent_app_date] => 2005-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 4352 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/893/07893216.pdf [firstpage_image] =>[orig_patent_app_number] => 11596271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225017 [patent_doc_number] => 20070254283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Brhf1 as a Cancer Diagnostic Marker' [patent_app_type] => utility [patent_app_number] => 10/591726 [patent_app_country] => US [patent_app_date] => 2005-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20320 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254283.pdf [firstpage_image] =>[orig_patent_app_number] => 10591726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225051 [patent_doc_number] => 20070254317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Method for Detecting the Activatable Free Form of Psa and the Use Thereof for Diagnosing Benign Pathologies of the Prostate and Adenocarcinoma of the Prostate' [patent_app_type] => utility [patent_app_number] => 10/590272 [patent_app_country] => US [patent_app_date] => 2005-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10976 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254317.pdf [firstpage_image] =>[orig_patent_app_number] => 10590272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7182835 [patent_doc_number] => 20050191306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/067390 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6139 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191306.pdf [firstpage_image] =>[orig_patent_app_number] => 11067390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 830281 [patent_doc_number] => 07399835 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/067366 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6949 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399835.pdf [firstpage_image] =>[orig_patent_app_number] => 11067366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7243241 [patent_doc_number] => 20050271630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Method for treating cancer' [patent_app_type] => utility [patent_app_number] => 11/059408 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5272 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271630.pdf [firstpage_image] =>[orig_patent_app_number] => 11059408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476445 [patent_doc_number] => 20100285004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Anti-CD38 human antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/588568 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16504 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285004.pdf [firstpage_image] =>[orig_patent_app_number] => 10588568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476445 [patent_doc_number] => 20100285004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Anti-CD38 human antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/588568 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16504 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285004.pdf [firstpage_image] =>[orig_patent_app_number] => 10588568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 435773 [patent_doc_number] => 07262028 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Recombinant production of mixtures of antibodies' [patent_app_type] => utility [patent_app_number] => 11/039767 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 32 [patent_no_of_words] => 34070 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262028.pdf [firstpage_image] =>[orig_patent_app_number] => 11039767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7039345 [patent_doc_number] => 20050158779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'PG-3 and biallelic markers thereof' [patent_app_type] => utility [patent_app_number] => 11/028971 [patent_app_country] => US [patent_app_date] => 2005-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 85326 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158779.pdf [firstpage_image] =>[orig_patent_app_number] => 11028971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432645 [patent_doc_number] => 07968690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Agonist anti-trkC antibodies and methods using same' [patent_app_type] => utility [patent_app_number] => 10/584443 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29546 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968690.pdf [firstpage_image] =>[orig_patent_app_number] => 10584443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7038890 [patent_doc_number] => 20050158324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Methods of therapy and diagnosis using targeting of cells that express BCLP polypeptides' [patent_app_type] => utility [patent_app_number] => 11/014487 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30498 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158324.pdf [firstpage_image] =>[orig_patent_app_number] => 11014487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4619351 [patent_doc_number] => 07999071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number of tandem repeat sequence of MUC-1' [patent_app_type] => utility [patent_app_number] => 10/582702 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 38329 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/999/07999071.pdf [firstpage_image] =>[orig_patent_app_number] => 10582702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5010472 [patent_doc_number] => 20070280951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Cell Death Inducing Agents' [patent_app_type] => utility [patent_app_number] => 10/582304 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11135 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20070280951.pdf [firstpage_image] =>[orig_patent_app_number] => 10582304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5613553 [patent_doc_number] => 20060115481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy' [patent_app_type] => utility [patent_app_number] => 11/000484 [patent_app_country] => US [patent_app_date] => 2004-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9826 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115481.pdf [firstpage_image] =>[orig_patent_app_number] => 11000484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5215634 [patent_doc_number] => 20070104715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Antibodies binding to a c-terminal fragment of apoliopoprotein e' [patent_app_type] => utility [patent_app_number] => 10/579445 [patent_app_country] => US [patent_app_date] => 2004-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 55152 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20070104715.pdf [firstpage_image] =>[orig_patent_app_number] => 10579445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 571167 [patent_doc_number] => 07462697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Methods for antibody engineering' [patent_app_type] => utility [patent_app_number] => 10/984473 [patent_app_country] => US [patent_app_date] => 2004-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15624 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462697.pdf [firstpage_image] =>[orig_patent_app_number] => 10984473 [rel_patent_id] =>[rel_patent_doc_number] =>)